# Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults

> **NCT00270218** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 66 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** VRC-HIVADV014-00-VP
- **BIOLOGICAL:** VRC-HIVDNA009-00-VP
- **BIOLOGICAL:** FFB
- **BIOLOGICAL:** PBS

## Key facts

- **NCT ID:** NCT00270218
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2021-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00270218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00270218, "Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00270218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*